Acceptance of Milestones Sample Clauses

Acceptance of Milestones. Each Milestone identified in an Implementation Plan shall be subject to the acceptance procedures set forth in this Section.
Sample 1Sample 2Sample 3See All (15)
AutoNDA by SimpleDocs
Acceptance of Milestones. SmartDisk shall deliver to Sony each milestone associated with a deliverable as set forth in the Development Schedule for review and approval by Sony. Sony will test the delivered milestone to determine whether such delivered milestone is in conformity with the Final Specifications. Sony will inform SmartDisk whether such delivered milestones are in conformity with the Final Specifications within the time periods set forth in the Development Schedule. In the event that a delivered milestone does not conform to the relevant portion of the Final Specification (such nonconformance will be referred to as "DEFICIENCIES"), Sony shall reject the delivered milestone and provide written notice to SmartDisk describing the Deficiencies in sufficient detail to allow SmartDisk to correct the Deficiencies. Within a period of time to be agreed between the parties after receiving each report regarding Deficiencies, SmartDisk will use its best commercial efforts to correct the Deficiencies so that the milestone conforms to the applicable part of the Final Specifications. The procedure in this Section 3.3 will be repeated with respect to a milestone to determine whether it is acceptable to Sony. In the event a delivered milestone fails to conform to the Final Specifications more than two times, the Program Managers shall meet to determine the appropriate course of action.
Sample 1Sample 2
Acceptance of Milestones. 1 2.3 Critical Milestones.................................................................................................................... 2 3. SERVICES............................................................................................................................................. 3 3.1 Objectives.................................................................................................................................. 3 3.2 Generally................................................................................................................................... 3 3.3 Cooperation with Regulatory Authorities................................................................................. 3 3.4 Complaints, Proceedings and Inquiries......................................…........................................... 4 3.5 Correspondence with Constituents............................................................................................ 4 3.6 Service Provider Laws............................................................................................................... 4
Sample 1
Acceptance of Milestones. Each milestone identified in a Transition Plan shall be subject to the acceptance procedures set forth in this Section 2.2.
Sample 1
Acceptance of Milestones. A milestone project approach w ill be used by Infor as outlined in the Project Scope section of this SOW. All milestones w ill require acceptance and sign off by the Licensee prior to Infor submitting the invoice to Licensee for payment. Infor w ill provide an acceptance request to Licensee for each milestone w hich details the completed deliverables associated w ith the milestone. The Licensee project manager w ill approve or disapprove each milestone w ithin 5 business days of notification from Infor. If upon review , the Licensee project manager determines the milestone to be completed and acceptable, the Licensee project manager w ill respond in w riting w ithin the 5 business day period that the milestone has been accepted and Infor w ill submit the invoice for that milestone to the Licensee. If Licensee does not accept or reject the milestone in w riting w ithin 5 business days, the milestone w ill be deemed accepted and Infor w ill submit the invoice for that milestone to the Licensee. If the milestone is not completed or acceptable, the Licensee w ill document in w riting any material nonconformity in the deliverable, and submit these details to the Infor project lead w ithin the 5 business day period. If Infor agrees that a material non-conformity exists in such deliverable, Infor w ill promptly correct any such nonconformity and resubmit that deliverable to Licensee for a second 5 business day review period, as set forth above. If a material nonconformity exists at the end of the second review period, Infor and Licensee w ill meet to create a mutually acceptable plan to complete such deliverable. Licensee w ill have main responsibility for the management of this project. LOCATIONS: Services may be provided at the facilities of Infor or its Contractors, or at the Licensee sites listed below . PAYMENT: Infor w ill invoice Licensee based on completion of milestones identified above.. Licensee w ill pay each Infor invoice w ithin fifteen (15) days of the date of invoice. THE PARTIES have executed this Work Order through the signatures of their respective authorized representatives. Infor (US), Inc. LICENSEE: Guilford County Signature: _ Signature: _ _ Printed Name: Printed Name: Title: Title: Address: Address: Address: Address: Signature Date: Signature Date: Inv oices MUSTbe mailed to: Deliv ery Address: If different from abov e Company Name: _ Company Name: _ Contact Name: ___ Contact Name: ___ Address:_________ _ _ _ _ Address: _______ Address: __...
Sample 1
Acceptance of Milestones. Upon completion of each milestone listed in a SOW, the 4SIGHT project manager will send an email with the summary of the activities completed by 4SIGHT and a request for Your approval. You must acknowledge and confirm successful completion of such milestone based on the requirements described in the applicable SOW (“Acceptance”) within seven days of such request, such Acceptance not to be unreasonably withheld. If You do not provide Acceptance within such time period, it will be deemed given. Any dispute of completion by You shall be accompanied by an explanation of the nonconformity with sufficient detail for 4SIGHT to cure such nonconformity and 4SIGHT shall have a reasonable opportunity to correct any such nonconformity. If You fail to provide Acceptance or dispute within the Acceptance period, the milestone will be deemed completed and You waive any right to dispute completion of such milestone.
Sample 1

Related to Acceptance of Milestones

  • Development Milestones In addition to its obligations under Paragraph 7.1, LICENSEE specifically commits to achieving the following development milestones in its diligence activities under this AGREEMENT: (a) (b).

  • Regulatory Milestones Celgene shall make the following approval milestone payments to Jounce that are set forth below upon the first achievement by or on behalf of Celgene, its Affiliates or Sublicensees of the Regulatory Milestone Events set forth below with respect to the first Co-Co Product that achieves such event. For clarity, each milestone set forth below shall be due and payable one time only (regardless of the number of Co-Co Products to achieve any such Regulatory Milestone Event). CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “[***]”. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. Regulatory Milestone Event (For the first Co-Co Product that achieves such event) Milestone Payments (in $ millions) [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] For each of Paragraphs (1) - (3) of this Exhibit C-2, the Parties understand and agree that in no event will more than one (1) milestone payment be paid with respect to any specific event triggering a payment under this Jounce Lead Co-Co Agreement.

  • Commercial Milestones In partial consideration of the rights granted by AstraZeneca to Licensee hereunder, Licensee shall pay to AstraZeneca the following payments, which shall be non-refundable, non-creditable and fully earned upon the first achievement of the applicable milestone event:

  • Development and Regulatory Milestones With respect to each of the following milestones, Ikaria shall pay BioLineRx the corresponding payment set forth below within [**] days after the achievement by Ikaria, its Affiliates or Licensees of such milestone: MILESTONE PAYMENT

  • Milestone Event Milestone Payment [***] [***]

  • Milestone A principal event specified in the Contract Documents including the Material Completion and Occupancy Date and other events relating to an intermediate completion date or time.

  • Development Milestone Payments In partial consideration for the rights and licenses granted to Coya hereunder, within ten days after the first achievement of each milestone event in a given Indication set forth in this Section 5.2 (Development Milestone Payments) with respect to a Product (each, a “Development Milestone Event”) by or on behalf of Coya or any of its Affiliates or Sublicensees, Coya shall provide ARScience Bio written notice to ARScience Bio identifying the Development Milestone Event achieved. Upon receipt of any such notice of first achievement of a Development Milestone Event by Coya or its Affiliates or Sublicensees, ARScience Bio will promptly invoice Coya for the applicable Development Milestone Event and Coya will make a milestone payment to ARScience Bio in the amount set forth in this Section 5.2 (Development Milestone Payments) corresponding to such Development Milestone Event (each, a “Development Milestone Payment”) within 45 days of receipt of such invoice. On an Indication-by-Indication basis, each Development Milestone Payment shall be payable only upon the first achievement of the corresponding Development Milestone Event by a Product, in any given Indication for which the Development Milestone Events have not been previously achieved (each such Indication, a “New Indication”). No amounts shall be due for subsequent or repeated achievements of such Development Milestone Event with respect to the same or different Mono Product or Combination Product, as applicable, in such Indication. Accordingly and for clarity, the Development Milestone Payment shall be paid only once, when first achieved by Coya, an Affiliate or a Sublicensee, but no payment shall be due if the same milestone is subsequently achieved by one of Coya, an Affiliate or a Sublicensee. For clarity, the amounts owed in Column (a) below shall be due for the first Combination Product to achieve the Development Milestone Events in a New Indication and the amounts owned in Column (c) below shall be due for the first Mono Product to achieve the Development Milestone Events in a New Indication. Any Combination Product or Mono Product to achieve the Development Milestone Events in a New Indication after the first achievement of the Development Milestone Events as described in the foregoing sentence will cause the amounts in Column (b) with respect to a Combination Product and Column (d) with respect to a Mono Product to be due and payable by Coya upon each such occurrence. If the first Product to achieve a Development Milestone Event in any Indication is a Combination Product, the amounts in Column (a) below shall be due and payable by Coya. If the next Product to achieve a Development Milestone Event in a New Indication is a Mono Product, the amounts in Column (c) below would be due and payable by Coya; provided, that if such next Product to achieve a Development Milestone Event in a New Indication is a Combination Product, the amounts in Column (b) would be due and payable by Coya. By way of example, if a Combination Product achieves IND Acceptance in ALS, and is the first Product to achieve a Development Milestone Event under this Agreement, [***] will be due and payable by Coya. If subsequently a Mono Product achieves IND Acceptance in ALS, no Development Milestone Payments will be due and payable by Coya under this Agreement. However, if subsequently any Combination Product achieves IND Acceptance in Alzheimer’s disease, [***] would be due and payable by Coya.

  • Commercial Milestone Payments For each Licensed Product, Licensee shall pay Arvinas the following one-time milestone event payments when the aggregate Net Sales of such Licensed Product in one or more particular country(ies) for a given calendar year (“Annual Net Sales”), where such Licensed Product is a Valid Claim Licensed Product at the time of sale in each of such country(ies), first achieves the corresponding threshold as set forth in this Section 6.3.2 below, subject to the terms of this Section 6.3 and the payment provisions in Article 7 below: Commercial Milestone Event Milestone Event Payment (US$)

  • Milestones Subject to the provisions of the SGIP, the Parties shall agree on milestones for which each Party is responsible and list them in Attachment 4 of this Agreement. A Party’s obligations under this provision may be extended by agreement. If a Party anticipates that it will be unable to meet a milestone for any reason other than a Force Majeure event, it shall immediately notify the other Parties of the reason(s) for not meeting the milestone and (1) propose the earliest reasonable alternate date by which it can attain this and future milestones, and (2) requesting appropriate amendments to Attachment 4. The Party affected by the failure to meet a milestone shall not unreasonably withhold agreement to such an amendment unless it will suffer significant uncompensated economic or operational harm from the delay, (1) attainment of the same milestone has previously been delayed, or (2) it has reason to believe that the delay in meeting the milestone is intentional or unwarranted notwithstanding the circumstances explained by the Party proposing the amendment.

  • Sales Milestones Subject to the terms and conditions set forth in the Agreement, in the event that the Annual Net Sales made by or on behalf of a Selling Entity for all Licensed Products in a given calendar year first exceeds a threshold set forth in the table immediately below, Pyxis shall pay to LCB the following one-time, non-refundable, non-creditable milestone payments. Annual Net Sales Milestone Threshold Payment (US Dollars) [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] In the event that in a given calendar year more than one (1) Annual Net Sales milestone threshold is achieved, Pyxis shall pay to LCB each separate Annual Net Sales milestone payment with respect to each Annual Net Sales milestone threshold that is achieved in such calendar year. Pyxis shall notify LCB in writing upon the first achievement, in respect of a Licensed Product, by or on behalf of Pyxis or its Affiliate or Sublicensee, of each of the Milestones set forth in Section 5.2 (Development Milestones), Section 5.3 (Regulatory Milestones) and Section 5.4 (Sales Milestones) no later than [***] of Pyxis’s knowledge of achievement thereof, and in any event, each of the Milestones set forth in Section 5.4 (Sales Milestones) no later than [***] after the end of the applicable calendar year in which such Milestone is achieved. No later than [***] of receipt of an appropriate invoice from LCB, Pyxis shall pay the applicable payment due upon achievement of the corresponding Milestone Event. Each Milestone Event shall be deemed to be achieved once for all Licensed Products and shall be payable only once.

Time is Money Join Law Insider Premium to draft better contracts faster.